Sesame Summit 2026 – application open

Startup World International Conference 2021

#entrepreneurship #technology #startup #business

Facts

Agenda:

  • 08:30am REGISTRATION
  • 09:00am OPENING SPEECH
  • 09:30am TALK Motivation (Devin Fidler)
  • 10:00am TALK Vision and Mission (Pankaj Maheshwari)
  • 10:30am TALK Funding (David S. Chen, Ph.D.)
  • 11:00am TALK C-level international business developer (Irina Spekman)
  • 11:30am TALK Technology (William Faloon)
  • 12:00pm PANEL (Devin Fidler, Pankaj Maheshwari, David S. Chen, Ph.D., Irina Spekman, William Faloon)
  • 01:00pm LUNCH AND NETWORKING
  • 02:00pm TALK Startups World (Thomas Ryden)
  • 02:30pm TALK Pitching (Giorgio Gaviraghi)
  • 03:00pm TALK Mentoring (Philip van Nedervelde)
  • 03:30pm TALK Team Work (Steven A. Garan, Ph.D.)
  • 04:00pm PANEL (Thomas Ryden, Giorgio Gaviraghi, Philip van Nedervelde, Steven A. Garan, Ph.D., Nuno Martins, Ph.D.)
  • 05:00pm DINNER AND NETWORKING
  • 06:00pm PARTY AND NETWORKING

Practical Information

Date: July 17, 2021
‌‌‌‌‌Address: Porto, Portugal
Language: English

Registration

startupsworld.net (€159 – €2460)

you might also like

Fundraising 32 seconds ago

European healthcare AI is experiencing a renaissance, driven by regulatory clarity from the AI Act and growing corporate adoption. Spiich Labs, a Stockholm-based startup developing AI-powered speech analysis for healthcare diagnostics, has secured €600k in pre-seed funding led by Tandem Health, with participation from Creandum founders and Ampli Ventures. The funding represents a strategic bet on the intersection of voice technology and healthcare, where European startups are carving out distinctive advantages through privacy-first approaches and regulatory compliance. AI healthcare funding attracts Nordic investors Tandem Health’s lead investment reflects the Swedish fund’s thesis around digital health infrastructure that can scale across fragmented European markets. The participation of Creandum founders signals strong conviction from operators who previously backed Spotify and Klarna through similar early-stage dynamics. “Speech analysis represents an untapped diagnostic frontier where European companies can lead globally,” noted a Tandem Health partner. “Spiich’s approach to privacy-preserving voice biomarkers aligns perfectly with European regulatory frameworks whilst addressing genuine clinical needs.” The investor mix combines healthcare-focused capital with generalist expertise, providing Spiich with both sector knowledge and scaling playbooks from Nordic success stories. Ampli Ventures’ involvement adds operational depth to the round. Voice biomarkers target European healthcare systems Spiich Labs is developing AI algorithms that analyse speech patterns to detect early indicators of neurological and respiratory conditions. The platform processes vocal biomarkers through machine learning models trained on European datasets, ensuring compliance with GDPR whilst building clinically relevant insights. The startup’s go-to-market strategy focuses initially on Nordic healthcare systems, where digital health adoption rates exceed European averages and procurement processes favour innovative solutions. Early pilots with Swedish hospitals have demonstrated diagnostic accuracy improvements of 15-20% for certain respiratory conditions. “European healthcare systems need diagnostic tools that integrate seamlessly with existing workflows whilst maintaining patient privacy,” explained the Spiich Labs CEO. “Our voice analysis platform delivers clinical insights without storing personal data, addressing two critical healthcare challenges simultaneously.” Funding will accelerate product development and support expansion across the Nordics, with plans for broader European deployment by 2026. The company competes with US-based voice AI startups but differentiates through European regulatory compliance and healthcare system integration. This funding positions Spiich within Europe’s growing voice technology ecosystem, where regulatory advantages and healthcare market access create defensible competitive moats. The pre-seed validates European investors’ appetite for AI healthcare solutions that leverage continental strengths.

Fundraising 39 minutes ago

Europe’s space sector is experiencing unprecedented momentum, driven by constellation deployment demands and sovereign technology imperatives. French satellite manufacturer U-Space has secured €24 million in Series A funding to accelerate its ambitious goal of producing one satellite per week, positioning itself as a critical player in Europe’s space manufacturing renaissance. The funding round brings together strategic European investors who recognise the urgent need for scaled satellite production capabilities within the continent. This injection of capital arrives at a pivotal moment when European governments are prioritising space sovereignty and commercial operators are demanding rapid deployment cycles. Series A satellite funding strengthens European space manufacturing The €24 million Series A round reflects growing investor confidence in Europe’s ability to compete with established space powers. While specific investor details weren’t disclosed, the funding structure suggests a mix of strategic and financial backers aligned with Europe’s space industrial policy objectives. This investment timing coincides with the European Space Agency’s increased focus on commercial partnerships and the growing recognition that Europe needs indigenous satellite manufacturing capacity to serve both institutional and commercial markets. The funding enables U-Space to scale beyond prototype development into serious production capabilities. European satellite manufacturers face unique challenges compared to their American counterparts, including fragmented market access and complex regulatory frameworks across member states. However, they benefit from strong institutional support and growing demand for sovereign space capabilities from both defence and commercial sectors. Scaling satellite production for European constellation demands U-Space’s ambitious target of weekly satellite production addresses a critical bottleneck in the European space sector. Traditional satellite manufacturing timelines measured in years are incompatible with modern constellation deployment requirements, where operators need hundreds or thousands of units delivered rapidly. The company’s approach focuses on standardised satellite platforms that can be customised for various mission requirements whilst maintaining production efficiency. This methodology mirrors successful automotive manufacturing principles, applying mass production techniques to traditionally bespoke space hardware. The €24 million will primarily fund production facility expansion, automated manufacturing equipment, and talent acquisition across engineering and production roles. This investment strategy reflects the capital-intensive nature of space manufacturing and the need for sustained funding to achieve meaningful scale. European constellation operators, from telecommunications providers to Earth observation companies, increasingly seek domestic suppliers capable of meeting their deployment schedules. Recent European space industry analysis indicates that production capacity, rather than technical capability, has become the primary constraint for European satellite manufacturers. U-Space’s Series A funding represents more than capital injection—it signals Europe’s determination to compete in the global satellite manufacturing arena. With weekly production targets and €24 million backing, the French company positions itself to serve the continent’s growing constellation requirements whilst reducing dependence on non-European suppliers.

Fundraising 3 hours ago

European manufacturers are increasingly turning to intelligent automation to address labour shortages and boost productivity. Against this backdrop, German quality assurance startup CERPRO has secured €2 million in seed funding to accelerate industrial workflows by up to 80%. The round was led by seed + speed Ventures, positioning the Berlin-based company to capitalise on the growing demand for AI-powered manufacturing solutions across Europe. Founded to transform how manufacturers approach quality control, CERPRO combines computer vision and machine learning to automate inspection processes that traditionally require manual oversight. The startup’s platform integrates seamlessly with existing production lines, offering European manufacturers a pathway to enhanced efficiency without wholesale infrastructure replacement. Seed funding targets industrial workflow acceleration seed + speed Ventures led the €2 million round, bringing their deep expertise in industrial technology investments to CERPRO’s growth trajectory. The Berlin-based VC has consistently backed European startups that digitise traditional industries, making this investment a strategic fit within their portfolio thesis. “CERPRO represents the future of quality assurance in European manufacturing,” explains a spokesperson from seed + speed Ventures. “Their ability to deliver immediate productivity gains while maintaining the precision European manufacturers demand makes them uniquely positioned in this market.” The investor’s backing signals confidence in CERPRO’s approach to solving real manufacturing challenges rather than pursuing abstract AI applications. The funding arrives as European manufacturers face mounting pressure to compete with lower-cost global competitors whilst maintaining quality standards. CERPRO’s solution addresses this challenge by enabling existing workforces to achieve significantly higher throughput without compromising accuracy. German startup targets European manufacturing transformation CERPRO’s technology stack differentiates itself through rapid deployment capabilities and integration flexibility. Unlike enterprise software that requires months of implementation, CERPRO’s platform can be operational within weeks, a crucial advantage for European manufacturers operating on tight margins. The startup plans to deploy the fresh capital across product development and market expansion throughout Germany and neighbouring European markets. “We’re seeing tremendous demand from manufacturers who need immediate productivity improvements,” notes CERPRO’s leadership team. “This funding allows us to scale our technology whilst expanding our engineering capabilities.” CERPRO competes in a fragmented European market where traditional quality assurance providers often lack the technological sophistication demanded by modern manufacturers. The company’s focus on workflow acceleration rather than mere automation positions it strategically against both established players and emerging competitors. With European manufacturers increasingly prioritising digital transformation initiatives, CERPRO’s timing appears optimal for rapid market penetration. This funding round reflects broader investor confidence in European industrial technology, particularly solutions that deliver measurable productivity gains. CERPRO’s ability to demonstrate up to 80% workflow acceleration provides the concrete value proposition that cautious European manufacturers require before adopting new technologies.

Subscribe to
our Newsletter!

Stay at the forefront with our curated guide to the best upcoming Tech events.